Boothbay Fund Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $951K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.96M | Sell |
|
|||||
|
2024
Q3 | $7.89M | Buy |
|
|||||
|
2024
Q2 | $5.48M | Sell |
|
|||||
|
2024
Q1 | $7.31M | Buy |
|
|||||
|
2023
Q4 | $2.13M | Buy |
|
|||||
|
2023
Q3 | $616K | Buy |
|
|||||
|
2023
Q2 | $395K | Sell |
|
|||||
|
2023
Q1 | $563K | Sell |
|
|||||
|
2022
Q4 | $2.07M | Sell |
|
|||||
|
2022
Q3 | $5.07M | Sell |
|
|||||
|
2022
Q2 | $8.28M | Buy |
|
|||||
|
2022
Q1 | $7.07M | Buy |
|
|||||
|
2021
Q4 | $5.06M | Buy |
|
|||||
|
2021
Q3 | $2.16M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $218K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $263K | Buy |
|